Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Winer

Showing results (81-90 of 113) with videos related to

Pageof 12
Sort By:
Blood|July 8, 2024
CRISPR-based rapid molecular diagnostic tests for fusion-driven leukemiasRahul S Vedula, Hannah Q Karp, Jeremy Koob, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 7, 2022
A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor-Positive Ovarian Cancer (Study 006)Janos L Tanyi, Leslie M Randall, Setsuko K Chambers, et al.
Blood|October 7, 2024
Asciminib plus dasatinib and prednisone for Philadelphia chromosome-positive acute leukemiaMarlise R Luskin, Mark A Murakami, Julia Keating, et al.
Experimental Hematology|December 18, 2021
Transcriptional differences between JAK2-V617F and wild-type bone marrow cells in patients with myeloproliferative neoplasmsDebra Van Egeren, Baransel Kamaz, Shichen Liu, et al.
The Lancet. Haematology|March 29, 2023
Eprenetapopt combined with venetoclax and azacitidine in TP53-mutated acute myeloid leukaemia: a phase 1, dose-finding and expansion studyGuillermo Garcia-Manero, Aaron D Goldberg, Eric S Winer, et al.
Blood Advances|May 16, 2019
Clinicopathologic and genetic characterization of nonacute <i>NPM1</i>-mutated myeloid neoplasmsSanjay S Patel, Caleb Ho, Ryan N Ptashkin, et al.
Leukemia & Lymphoma|March 15, 2022
Outcomes of antifungal prophylaxis for newly diagnosed AML patients treated with a hypomethylating agent and venetoclaxEvan C Chen, Yiwen Liu, Courtney E Harris, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|February 2, 2013
Clinical and pathologic characteristics of serous carcinoma confined to the endometrium: a multi-institutional studyAssaad Semaan, Ismail Mert, Adnan R Munkarah, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 15, 2023
Cutaneous Manifestations of Myeloid Neoplasms Exhibit Broad and Divergent Morphologic and Immunophenotypic Features but Share Ancestral Clonal Mutations With Bone MarrowSam Sadigh, Daniel J DeAngelo, Jacqueline S Garcia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2022
Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction CorrelatesEvan C Chen, Helen Gandler, Isidora Tošić, et al.
Pageof 12

Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
Blood|July 8, 2024
CRISPR-based rapid molecular diagnostic tests for fusion-driven leukemiasRahul S Vedula, Hannah Q Karp, Jeremy Koob, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 7, 2022
A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor-Positive Ovarian Cancer (Study 006)Janos L Tanyi, Leslie M Randall, Setsuko K Chambers, et al.
Blood|October 7, 2024
Asciminib plus dasatinib and prednisone for Philadelphia chromosome-positive acute leukemiaMarlise R Luskin, Mark A Murakami, Julia Keating, et al.
Experimental Hematology|December 18, 2021
Transcriptional differences between JAK2-V617F and wild-type bone marrow cells in patients with myeloproliferative neoplasmsDebra Van Egeren, Baransel Kamaz, Shichen Liu, et al.
The Lancet. Haematology|March 29, 2023
Eprenetapopt combined with venetoclax and azacitidine in TP53-mutated acute myeloid leukaemia: a phase 1, dose-finding and expansion studyGuillermo Garcia-Manero, Aaron D Goldberg, Eric S Winer, et al.
Blood Advances|May 16, 2019
Clinicopathologic and genetic characterization of nonacute <i>NPM1</i>-mutated myeloid neoplasmsSanjay S Patel, Caleb Ho, Ryan N Ptashkin, et al.
Leukemia & Lymphoma|March 15, 2022
Outcomes of antifungal prophylaxis for newly diagnosed AML patients treated with a hypomethylating agent and venetoclaxEvan C Chen, Yiwen Liu, Courtney E Harris, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|February 2, 2013
Clinical and pathologic characteristics of serous carcinoma confined to the endometrium: a multi-institutional studyAssaad Semaan, Ismail Mert, Adnan R Munkarah, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 15, 2023
Cutaneous Manifestations of Myeloid Neoplasms Exhibit Broad and Divergent Morphologic and Immunophenotypic Features but Share Ancestral Clonal Mutations With Bone MarrowSam Sadigh, Daniel J DeAngelo, Jacqueline S Garcia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2022
Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction CorrelatesEvan C Chen, Helen Gandler, Isidora Tošić, et al.
Pageof 12